Sposito M, Truffarelli F, De Giorgi G, Sabalich I, Britta R, Cova L, Rufini S
Istituto di Pediatria, Università di Perugia, Italia.
Pediatr Med Chir. 1995 Jan-Feb;17(1):41-4.
Serum IGFBP3 levels were tested in 7 GHD children before the rGH therapy, at the end of the same therapy and 1, 2, 4, and 8 weeks later. The IGFBP3 concentration returned to the pre-therapy levels only 6 weeks after the end of the therapy.
对7名生长激素缺乏症(GHD)儿童在重组人生长激素(rGH)治疗前、治疗结束时以及治疗结束后1周、2周、4周和8周检测血清胰岛素样生长因子结合蛋白3(IGFBP3)水平。IGFBP3浓度在治疗结束后仅6周就恢复到治疗前水平。